Open AccessCardio-Renal Benefits of GLP-1 Receptor Agonists vs. SGLT-2 Inhibitors in Type 2 Diabetes: Are They Juxtaposed?
Author(s) -
Awadhesh Kumar Singh,
Viral N. Shah
Publication year - 2022
Publication title -
clinical diabetology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.152
H-Index - 4
eISSN - 2450-8187
pISSN - 2450-7458
DOI - 10.5603/dk.a2022.0037
Subject(s) - medicine , type 2 diabetes , glucagon like peptide 1 receptor , endocrinology , diabetes mellitus , pharmacology , receptor , agonist